A Second Clinical Trial to Evaluate Temozolomide (Kimozo) in Pediatric Patients
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Temozolomide (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- Sponsors ORPHELIA Pharma
- 09 Oct 2020 New trial record
- 05 Oct 2020 According to an ORPHELIA Pharma media release, the company is now preparing the opening of the second clinical trial, which will evaluate Kimozo in pediatric patients, by the end of the year.